Cent Eur J Public Health 2017, 25(Suppl 2):S10-S15 | DOI: 10.21101/cejph.a4955

Disparities of potential gains in life expectancy development between the Slovak Republic and the Czech Republic

Tatiana Vagašová, Beáta Gavurová
Faculty of Economics, Technical University of Košice, Košice, Slovak Republic

Aim: The purpose of this paper is to determine how many years a person could be expected to live if a specific cause of death was eliminated, and to compare potential gains in life expectancy (PGLEs) between Slovakia (SVK) and the Czech Republic (CZE).

Methods: PGLEs were computed from mortality reports (1996-2013) for deaths from the main groups of chronic diseases, namely ischaemic heart disease (IHD), cerebrovascular diseases (CVD), cancer (CA), diabetes mellitus (DM), and chronic respiratory diseases (CRD) for the Slovak and Czech populations in five-year age groups. Country comparative analysis was conducted by constructing rate ratios of PGLEs.

Results: In 2013, life expectancy at birth for the Slovak and Czech populations was 76.5 and 78.3 years. Overall trends of standardised mortality rates of chronic diseases roughly paralleled the PGLEs trend. During 1996-2013, SVK reported the highest PGLEs of IHD at an average of 4.54 years, compared to PGLEs of CA reaching a value of 3.61 years in CZE. The PGLEs of IHD showed the largest gap between SVK and CZE, with an average of 1.65 higher values in SVK. With the elimination of CVD as the third most influential disease in both countries, PGLEs decreased from 1.65 to 0.93 years in CZE; a negligible drop from 1.13 to 1.05 was recorded in SVK. The lowest impacts on life expectancy were recorded in DM and CRD. However, since 2005 these trends have deteriorated in CZE. In 2013, IHD had a similar impact on life expectancy in all age groups in SVK and a decreasing impact among 50-54 year olds in CZE. Similarly to SVK, people in CZE aged 45-49 could gain 0.94 years in LE after CVD elimination, which is nearly the same as at birth.

Conclusions: The higher the life expectancy after elimination of the cause of death is, the higher the impact of the disease on life expectancy. Health prevention programs should be mainly aimed at CA mortality in CZE, while the highest burden of IHD is seen in SVK.

Klíčová slova: life expectancy, potential gains in life expectancy, standardised mortality rate, non-communicable diseases, Slovak Republic, Czech Republic

Vloženo: 17. říjen 2016; Revidováno: 19. prosinec 2017; Zveřejněno: 30. prosinec 2017  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vagašová T, Gavurová B. Disparities of potential gains in life expectancy development between the Slovak Republic and the Czech Republic. Cent Eur J Public Health. 2017;25(Supplement 2):S10-15. doi: 10.21101/cejph.a4955. PubMed PMID: 29524364.
Sdílet...
Stáhnout citaci
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Zobrazit celý článek

    Reference

    1. OECD.Stat. Health Status: Life expectancy [Internet]. [cited 2016 Apr 10]. Available from: http://stats.oecd.org/Index.aspx?DatasetCode=HEALTH_STAT.
    2. CPHR. National Human Development Report Slovak Republic 2001-2002. Bratislava: UNDP; 2002. (In Slovak.)
    3. Maresova P, Mohelska H, Dolejs J, Kuca K. Socio-economic aspects of Alzheimer's Disease. Curr Alzheimer Res. 2015;12(9):903-11. Přejít k původnímu zdroji... Přejít na PubMed...
    4. Gajdos O, Loncak V, Bartak M, Rogalewicz V. Cost of illness study of type 2 diabetes mellitus in the newly established diabetology outpatient facility in the Czech Republic. Value Health. 2015;18(7):A603-4. Přejít k původnímu zdroji... Přejít na PubMed...
    5. WHO. Global health risks: mortality and burden of disease attributable to selected major risks [Internet]. Geneva: WHO; 2009 [cited 2016 May 10]. Available from: http://www.who.int/healthinfo/global_burden_disease/global_health_risks/en/.
    6. OECD. Health at a Glance 2015: OECD Indicators [Internet]. Paris: OECD Publishing; 2015 [cited 2016 Apr 6]. Available from: http://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2015_health_glance-2015-en.
    7. Mohelska H, Maresova P, Valis M, Kuca K. Alzheimer's disease and its treatment costs: case study in the Czech Republic. Neuropsychiatr Dis Treat. 2015 Sep 11;11:2349-54. Přejít k původnímu zdroji...
    8. Zelený T, Bencko V. Healthcare system financing and profits: all that glitters is not gold. Cent Eur J Public Health. 2015;23(1):3-7. Přejít k původnímu zdroji... Přejít na PubMed...
    9. Ucieklak-Jez P, Bem A, Predkiewicz P. Effectiveness of allocation of health system non-financial resources. In: Bratianu C, Zbuchea A, Pinzaru F, Vatamanescu EM, Leon RD, editors. Local versus global. Strategica: International Academic Conference; 2015 Oct 29-31; Bucharest. Bucharest: SNSPA; 2015. p. 647-56.
    10. Mackenbach JP, Kunst AE, Lautenbach H, Oei YB, Bijlsma F. Gains in life expectancy after elimination of major causes of death: revised estimates taking into account the effect of competing causes. J Epidemiol Community Health. 1999 Jan;53(1):32-7. Přejít k původnímu zdroji... Přejít na PubMed...
    11. Lai D, Hardy RJ. Potential gains in life expectancy or years of potential life lost: impact of competing risks of death. Int J Epidemiol. 1999 Oct;28(5):894-8. Přejít k původnímu zdroji... Přejít na PubMed...
    12. Liu P, Li Ch, Wang Y, Zeng W, Wang H, Wu H, et al. The impact of the major causes of death on life expectancy in China: a 60-year longitudinal study. BMC Public Health. 2014 Nov 20;14:1193. doi: 10.1186/1471-2458-14-1193. Přejít k původnímu zdroji... Přejít na PubMed...
    13. Conti S, Farchi G, Masocco M, Toccaceli V, Vichi M. The impact of the major causes of death on life expectancy in Italy. Int J Epidemiol. 1999;28(5):905-10. Přejít k původnímu zdroji... Přejít na PubMed...
    14. Bleha B, Šprocha B, Vaňo B. Prognosis of population development in the Slovak Republic up to 2060. Bratislava: INFOSTAT; 2013. (In Slovak.)
    15. Burcin B, Kučera T. Structural changes in mortality in the Czech Republic and Slovakia between 1991 and 2006. Demografie. 2008; 50:173-85. (In Czech.)
    16. Mészáros J. Mortality. In: Vaňo B, editor. Population development in the Slovak Republic in 2011. Bratislava: INFOSTAT; 2011. p. 53-64. (In Slovak.)
    17. Gavurová B, Vagašová T. Regional differences of standardised mortality rates for ischemic heart diseases in the Slovak Republic for the period 1996-2013 in the context of income inequality. Health Econ Rev. 2016;6:21. doi:10.1186/s13561-016-0099-1. Přejít k původnímu zdroji... Přejít na PubMed...
    18. Šoltés V, Gavurová B. The possibilities of day surgery system development within the health policy in Slovakia. Health Econ Rev. 2014;4:35. doi:10.1186/s13561-014-0035-1. Přejít k původnímu zdroji... Přejít na PubMed...
    19. Mészáros J. Methodological guide. The calculation of life tables. The calculation of Potential Years of Life Lost. Bratislava: INFOSTAT; 2000. (In Slovak.)
    20. Arias E, Heron M, Tejada-Vera B. United States life tables eliminating certain causes of death, 1999-2001. Natl Vital Stat Rep. 2013;61(9):1-128.
    21. European Commision. Revision of the European Standard Population. Report of Eurostat's task force. Luxembourg: Publications Office of the European Union; 2013.
    22. Burcin B, Kučera T. Long-term trends in mortality of the population of the Czech Republic in the European context. In: Fialová L, et al. Population development in the Czech Republic 2007. Prague: Charles University, Faculty of Science; 2008. p. 111-25. (In Czech.)
    23. Zachar D. The reform process in health care system - 2000-2012. In: Morvay K, editor. Health care system - markets, regulation and policy. Bratislava: INEKO; 2012. (In Slovak.)
    24. Leyland AH, Dundas R, McLoone P, Boddy FA. Inequalities in mortality in Scotland, 1981-2001. Glasgow: MRC Social and Public Health Sciences Unit; 2007.
    25. Shiels MS, Chernyavskiy P, Anderson WF, Best AF, Haozous EA, Hartge P, et al. Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data. Lancet. 2017;389(10073):1043-54. Přejít k původnímu zdroji... Přejít na PubMed...
    26. Zajacova A, Montez JK. Macro-level perspective to reverse recent mortality increases. Lancet. 2017;389(10073):991-2. Přejít k původnímu zdroji... Přejít na PubMed...

    Zpět na obsah